IMpassion132 Phase III trial: atezolizumab and chemotherapy in early relapsing metastatic triple-negative breast cancer
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
12 Apr 2019
|
| In: |
Future oncology
Year: 2019, Volume: 15, Issue: 17, Pages: 1951-1961 |
| ISSN: | 1744-8301 |
| DOI: | 10.2217/fon-2019-0059 |
| Online Access: | Verlag: https://www.futuremedicine.com/doi/10.2217/fon-2019-0059 Resolving-System: https://doi.org/10.2217/fon-2019-0059 |
| Author Notes: | Javier Cortés, Fabrice André, Anthony Gonçalves, Sherko Kümmel, Miguel Martín, Peter Schmid, Florian Schuetz, Sandra M. Swain, Valerie Easton, Erika Pollex, Regula Deurloo & Rebecca Dent |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1682417956 | ||
| 003 | DE-627 | ||
| 005 | 20220817162328.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191121s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2217/fon-2019-0059 |2 doi | |
| 035 | |a (DE-627)1682417956 | ||
| 035 | |a (DE-599)KXP1682417956 | ||
| 035 | |a (OCoLC)1341278509 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Cortes, Javier |e VerfasserIn |0 (DE-588)142653705 |0 (DE-627)638445590 |0 (DE-576)332633640 |4 aut | |
| 245 | 1 | 0 | |a IMpassion132 Phase III trial |b atezolizumab and chemotherapy in early relapsing metastatic triple-negative breast cancer |c Javier Cortés, Fabrice André, Anthony Gonçalves, Sherko Kümmel, Miguel Martín, Peter Schmid, Florian Schuetz, Sandra M. Swain, Valerie Easton, Erika Pollex, Regula Deurloo & Rebecca Dent |
| 264 | 1 | |c 12 Apr 2019 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 21.11.2019 | ||
| 700 | 1 | |a André, Fabricé |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gonçalves, Anthony |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kümmel, Sherko |d 1971- |e VerfasserIn |0 (DE-588)122704142 |0 (DE-627)082103372 |0 (DE-576)293388016 |4 aut | |
| 700 | 1 | |a Martin, Miguel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schmid, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schütz, Florian |d 1972- |e VerfasserIn |0 (DE-588)12303387X |0 (DE-627)082307229 |0 (DE-576)293528810 |4 aut | |
| 700 | 1 | |a Easton, Valerie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Swain, Sandra M. |e VerfasserIn |0 (DE-588)1136982418 |0 (DE-627)893903809 |0 (DE-576)491013728 |4 aut | |
| 700 | 1 | |a Pollex, Erika |e VerfasserIn |4 aut | |
| 700 | 1 | |a Deurloo, Regula |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dent, Rebecca |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Future oncology |d London : Taylor & Francis, 2005 |g 15(2019), 17, Seite 1951-1961 |h Online-Ressource |w (DE-627)484405055 |w (DE-600)2184533-5 |w (DE-576)398100217 |x 1744-8301 |7 nnas |a IMpassion132 Phase III trial atezolizumab and chemotherapy in early relapsing metastatic triple-negative breast cancer |
| 773 | 1 | 8 | |g volume:15 |g year:2019 |g number:17 |g pages:1951-1961 |g extent:11 |a IMpassion132 Phase III trial atezolizumab and chemotherapy in early relapsing metastatic triple-negative breast cancer |
| 856 | 4 | 0 | |u https://www.futuremedicine.com/doi/10.2217/fon-2019-0059 |x Verlag |
| 856 | 4 | 0 | |u https://doi.org/10.2217/fon-2019-0059 |x Resolving-System |
| 951 | |a AR | ||
| 992 | |a 20191121 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 12303387X |a Schütz, Florian |m 12303387X:Schütz, Florian |d 910000 |d 910400 |d 50000 |e 910000PS12303387X |e 910400PS12303387X |e 50000PS12303387X |k 0/910000/ |k 1/910000/910400/ |k 0/50000/ |p 7 | ||
| 999 | |a KXP-PPN1682417956 |e 3544047578 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 21.11.2019"],"recId":"1682417956","type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"subtitle":"atezolizumab and chemotherapy in early relapsing metastatic triple-negative breast cancer","title":"IMpassion132 Phase III trial","title_sort":"IMpassion132 Phase III trial"}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","given":"Javier","display":"Cortes, Javier","family":"Cortes"},{"given":"Fabricé","role":"aut","roleDisplay":"VerfasserIn","display":"André, Fabricé","family":"André"},{"display":"Gonçalves, Anthony","role":"aut","roleDisplay":"VerfasserIn","given":"Anthony","family":"Gonçalves"},{"family":"Kümmel","display":"Kümmel, Sherko","given":"Sherko","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Martin","display":"Martin, Miguel","given":"Miguel","role":"aut","roleDisplay":"VerfasserIn"},{"family":"Schmid","roleDisplay":"VerfasserIn","role":"aut","given":"Peter","display":"Schmid, Peter"},{"display":"Schütz, Florian","role":"aut","roleDisplay":"VerfasserIn","given":"Florian","family":"Schütz"},{"family":"Easton","display":"Easton, Valerie","role":"aut","roleDisplay":"VerfasserIn","given":"Valerie"},{"display":"Swain, Sandra M.","role":"aut","roleDisplay":"VerfasserIn","given":"Sandra M.","family":"Swain"},{"display":"Pollex, Erika","roleDisplay":"VerfasserIn","role":"aut","given":"Erika","family":"Pollex"},{"family":"Deurloo","given":"Regula","role":"aut","roleDisplay":"VerfasserIn","display":"Deurloo, Regula"},{"display":"Dent, Rebecca","given":"Rebecca","roleDisplay":"VerfasserIn","role":"aut","family":"Dent"}],"language":["eng"],"name":{"displayForm":["Javier Cortés, Fabrice André, Anthony Gonçalves, Sherko Kümmel, Miguel Martín, Peter Schmid, Florian Schuetz, Sandra M. Swain, Valerie Easton, Erika Pollex, Regula Deurloo & Rebecca Dent"]},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"12 Apr 2019"}],"id":{"eki":["1682417956"],"doi":["10.2217/fon-2019-0059"]},"physDesc":[{"extent":"11 S."}],"relHost":[{"disp":"IMpassion132 Phase III trial atezolizumab and chemotherapy in early relapsing metastatic triple-negative breast cancerFuture oncology","language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedKey":"2005","publisherPlace":"London ; London","publisher":"Taylor & Francis ; Future Medicine Ltd","dateIssuedDisp":"2005-"}],"title":[{"title":"Future oncology","title_sort":"Future oncology"}],"id":{"zdb":["2184533-5"],"eki":["484405055"],"issn":["1744-8301"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.2005 -"],"recId":"484405055","part":{"issue":"17","volume":"15","pages":"1951-1961","extent":"11","year":"2019","text":"15(2019), 17, Seite 1951-1961"},"note":["Gesehen am 28.05.2024"]}]} | ||
| SRT | |a CORTESJAVIIMPASSION11220 | ||